CIPLA:NSE
Cipla Ltd
၁,၃၄၂.၄၀ ₹
arrow_upward
+၀.၅၂%(+၆.၉၀) 1D
အောက် ၆, GMT+၅:၃၀ ၁၅:၃၀:၀၀ · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CIPLA...
Open
၁,၃၃၅.၀၀ ₹
High
၁,၃၄၄.၉၀ ₹
Low
၁,၃၂၃.၂၀ ₹
Mkt. cap
ဋေ ၁.၀၉ သိန်း
Avg. vol.
၉.၃၇ သိန်း
Volume
၅.၇၆ သိန်း
Dividend
၀.၉၇%
Quarterly dividend
၃.၂၅ ₹
Ex-dividend date
၂၀၂၆ ဇွန် ၅
P/E ratio
၃၂.၁၉
52-wk high
၁,၆၇၃.၀၀ ₹
52-wk low
၁,၁၆၅.၇၀ ₹
EPS
၄၁.၇၀ ₹
Shares outstanding
၈၀.၅၇ ကုဋေ
No. of employees
၃ သောင်း
Open
၁,၃၃၅.၀၀ ₹
High
၁,၃၄၄.၉၀ ₹
Low
၁,၃၂၃.၂၀ ₹
Mkt. cap
ဋေ ၁.၀၉ သိန်း
Avg. vol.
၉.၃၇ သိန်း
Volume
၅.၇၆ သိန်း
Dividend
၀.၉၇%
Quarterly dividend
၃.၂၅ ₹
Ex-dividend date
၂၀၂၆ ဇွန် ၅
P/E ratio
၃၂.၁၉
52-wk high
၁,၆၇၃.၀၀ ₹
52-wk low
၁,၁၆၅.၇၀ ₹
EPS
၄၁.၇၀ ₹
Shares outstanding
၈၀.၅၇ ကုဋေ
No. of employees
၃ သောင်း
News stories
From web sources and news partners
Benzinga
·
ပြီးခဲ့သည့် ၁ နာရီ
BOXABL (NASDAQ: BXBL) Adds Former EY Audit Partner Timothy Goldsmith to Board as Audit Committee Chair
The Washington Post
·
ပြီးခဲ့သည့် ၄၁ မိနစ်
Stocks hit new record high even as consumers feel dreary
MarketForces Africa
·
ပြီးခဲ့သည့် ၁၃ မိနစ်
XRP Establishes Price Floor Ahead Of Evernorth Nasdaq Listing
The Motley Fool
·
ပြီးခဲ့သည့် ၅၄ မိနစ်
Stock Market Midday, Oct. 6: S&P 500 Sets New High, Nuclear Stocks Surge
Profile
Cipla Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, paediatric and various other medical conditions. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India. Wikipedia
About Cipla Ltd
CEOUmang Vohra
Employees၃.၁၄ သောင်း
Founded၁၉၃၅
Headquartersမွမ်ဘိုင်းမြို့, မဟာရာရှ်ထရာ, အိန္ဒိယ
Sector-
Websitecipla.com